Last month marked 25 years since the Food and Drug Administration approved the abortion drug mifepristone, then called RU-486, for use in the United States.
On September 19, Health and Human Services Secretary Robert F. Kennedy, Jr., and the FDA Commissioner Marty Makary, sent a letter to 22 pro-life state attorneys general informing them that the agencies will perform a review of the drug’s safety.
Such a review is long overdue and should result in the revocation of the FDA’s approval of mifepristone or, at minimum, the restoration of important protections around the drug’s prescription.
Since sending that letter, the FDA unexpectedly approved a generic form of the chemical abortion drug. RFK, Jr., and Dr. Makary have regulatory tools at their disposal that could begin the process of removing these dangerous drugs from the market. It is time for them to take decisive action.
The FDA first approved mifepristone in 2000 under a regulation known as Subpart H which allows for the expedited approval of drugs that treat “serious or life-threatening illnesses” and that provide a “meaningful therapeutic benefit to patients over existing treatments.” Mifepristone meets neither of these requirements.
First, mifepristone does not “treat” a “serious or life-threatening illness.” Pregnancy is not an illness and killing an unborn child is not treatment.
Second, chemical abortion does not now, and certainly did not then, provide a “meaningful therapeutic benefit . . . over existing treatments.” As a 2006 <a href="https://advancingamericanfreedom.com/mifepristone-resource-congressional-staff-report-the-fda-and-ru-486-lowering-the-standard-for-womens-health/" target="_blank" rel="noopener">congressional report</a> on mifepristone’s approval explained, “it appears that no concurrently-controlled trials comparing medical and surgical abortion were required by FDA, because the Agency already knew that medical abortion—i.e., abortion by RU-486—is unambiguously inferior to surgical abortion with respect to safety and effectiveness.”
Nor, as the same report lays out in detail, did the FDA rely on studies of sufficient rigor to meet Subpart H’s requirements.
How could the FDA so blatantly disregard its own rules? Because the approval of chemical  abortion was <a href="https://humanlifereview.com/playing-politics-with-the-abortion-pill-a-quarter-century-of-abuse-of-power-at-the-fda/" target="_blank" rel="noopener">political from the start</a>.
In his <a href="https://url.avanan.click/v2/r01/___https:/advancingamericanfreedom.com/mifepristone-resource-judicial-watch-special-report-the-clinton-ru-486-files/___.YXAzOmFhZjphOm86YmM2NTQ4Zjk3MDAzZTY4MjA0NDM5NzQyZjdmNzQ4NGU6Nzo4ZDhkOjI3ZDY5MjU2MWJkOTU4OTZlNjNjYmUwMDI3ZmZjODA5NGMzNmZjYzNiYWU2NDk5MGYxZDE0MmIzNGE0Y2JiNjA6aDpUOk4" target="_blank" rel="noopener">first official act</a> as President, Bill Clinton directed HHS to promote the introduction of the abortion drug into the American market. Over the next seven years, the Clinton administration worked to have the patent rights transferred to the Population Council, which then sought the FDA’s approval.  That transfer of patent rights was necessitated by the fact that the French company that owned the patent was unwilling to introduce the drug to the American market without indemnification of liability for the harms it would foreseeably cause.
<a class="c-link" href="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial" target="_blank" rel="noopener noreferrer" data-stringify-link="https://get.dailywire.com/subscribe/plus/?utm_campaign=fall40&amp;utm_content=fallsale&amp;utm_medium=website&amp;utm_source=editorial" data-sk="tooltip_parent">Get 40% off new DailyWire+ annual memberships with code FALL40 at checkout!</a>
Upon approval of mifepristone, the FDA implemented certain limitations on the drug’s prescription to provide at least some protection to women. <a href="https://url.avanan.click/v2/r01/___https:/storage.courtlistener.com/recap/gov.uscourts.txnd.370067/gov.uscourts.txnd.370067.137.0_20.pdf___.YXAzOmFhZjphOm86YmM2NTQ4Zjk3MDAzZTY4MjA0NDM5NzQyZjdmNzQ4NGU6Nzo3MWI3OjEzNTE0ZGZhZjY0OTJkZGEwMzg2NmU3ZDRhYjFjYjlhZjQ2MDZiMzc2MzEyMDEzZjNkMmQ4NzgyYTJhOTEwNDY6aDpUOk4" target="_blank" rel="noopener">Specifically,</a> the abortion drug could only be prescribed to women who were less than seven weeks pregnant, women were required to visit the doctor three times, and abortionists were required to report all adverse events.
These restrictions did not make mifepristone safe, but they did reduce the risk of harm to women. For example, in-person consultations provided women with necessary procedures, such as ultrasounds, critical for recognizing ectopic pregnancies, which, if left untreated, are deadly.
In March 2016, the Obama FDA significantly <a href="https://url.avanan.click/v2/r01/___https:/storage.courtlistener.com/recap/gov.uscourts.txnd.370067/gov.uscourts.txnd.370067.137.0_20.pdf___.YXAzOmFhZjphOm86YmM2NTQ4Zjk3MDAzZTY4MjA0NDM5NzQyZjdmNzQ4NGU6NzozMzQ4OjU0ZDdkY2E2NzEzOWExMDlmZTU0NzVjM2QwMTdkZmFjOGE1YzcxNzc3NTU2OWI3OTg4NzIxOGFlMjJhNjViYTc6aDpUOk4" target="_blank" rel="noopener">reduced</a> these protections, now referred to as a Risk Evaluation and Mitigation Strategy (REMS). Under the updated REMS, women could be prescribed mifepristone for abortions up to 10 weeks’ gestation and only needed to visit a doctor once, non-doctors were allowed to prescribe chemical abortions, and abortionists were only required to report fatal adverse events.
In 2021, the FDA “<a href="https://url.avanan.click/v2/r01/___https:/storage.courtlistener.com/recap/gov.uscourts.txnd.370067/gov.uscourts.txnd.370067.137.0_20.pdf___.YXAzOmFhZjphOm86YmM2NTQ4Zjk3MDAzZTY4MjA0NDM5NzQyZjdmNzQ4NGU6Nzo2ZGViOmVkNjQ0OWNmMjVmNWFiNzUyNDhjYzZkNGE2NzAxODU0ZTkyNjcwNGIzMDIzOWQyMGI0YWY5YjY2NjJkMDdlMzI6aDpUOk4" target="_blank" rel="noopener">removed</a> the ‘in-person dispensing requirement’” altogether.
In 2023, <a href="https://url.avanan.click/v2/r01/___https:/nrlc.org/nrlnewstoday/2024/03/guttmacher-says-abortions-increased-after-dobbs/___.YXAzOmFhZjphOm86YmM2NTQ4Zjk3MDAzZTY4MjA0NDM5NzQyZjdmNzQ4NGU6NzpjZjQ2OmNhNDQ5Mzc5ZWY2OGZhYjg5MjYyMDNlM2RhZGU5NGU3MDU2YjE3M2YwMzlhNjQwMGYwMmYzNmI2MTkyMWIyMDg6aDpUOk4" target="_blank" rel="noopener">63%</a> of abortions were chemical rather than surgical, and <a href="https://url.avanan.click/v2/r01/___https:/www.guttmacher.org/report/stability-number-abortions-2023-2024-us-states-without-total-bans-masks-major-shifts-access___.YXAzOmFhZjphOm86YmM2NTQ4Zjk3MDAzZTY4MjA0NDM5NzQyZjdmNzQ4NGU6Nzo0N2Q2OjFlMjhlNWE0NzQxODVlNWZiZDQ4YThmZWE5ODIzNTFkZTNlOWM3NWM5MGY4ZjJlOWI2NzY2YmM3ZGJmNDM4ZjI6aDpUOk4" target="_blank" rel="noopener">tens of thousands</a> of chemical abortions were shipped into pro-life states in 2024.
The FDA’s review of the dangers of mifepristone to women’s health is long overdue. A recent study by the Ethics and Public Policy Center suggesting that the adverse event rate for chemical abortion is much higher than FDA data suggests, is only the most recent in two and a half decades of evidence that the FDA’s approval of the drug is dangerous for women.
Armed with this and other data, the heads of HHS and the FDA have legal authority to <a href="https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-314/subpart-D/section-314.150" target="_blank" rel="noopener">call for a hearing</a> to determine whether the FDA’s initial approval of mifepristone should be withdrawn. This would be an important step toward removing dangerous chemical abortion drugs from the market, and allow the agency to delay approval of any other generic forms of mifepristone currently being considered.
For the past 25 years, mifepristone has been used to terminate innocent human life while injuring and harming women for life. The abortion drug’s reckoning is long overdue. The FDA’s recently announced review is a good first step, but pro-life Americans cannot rest until the dangerous chemical abortion pill is taken off the market and pre-born Americans are safe from its harms.
Marc Wheat is general counsel for Advancing American Freedom.
<div>
<div id="post-body-text" class="css-1ec96ji">
<div class="eo63h7k0 css-1mqhe4y">
The views expressed in this piece are those of the author and do not necessarily represent those of The Daily Wire.
</div>
</div>
</div>

HHS Secretary Kennedy Holds News Conference On Synthetic Dyes In Food Supply

The FDA’s Review Of Abortion Drugs Is Long Overdue

Abortion

Abortion Drug

Robert F. Kennedy Jr.

This week, the House Judiciary Committee held a hearing titled “How Leftist Nonprofit Networks Exploit Federal Tax Dollars to Advance a Radical Agenda,” a look into how USAID, which was partially defunded by Congress this week, has been abused for radical causes abroad.
Nearly 20 years ago, one such scandal inspired an online database to try to weed out the worst offenders. American contractors funded by the State Department and local police staged a daring raid on a brothel in India, rescuing a number of young girls from sexual slavery. But within days, a prostitute union funded by USAID pressured the girls to stop cooperating with investigators and return to the brothel, where they were once again subjected to rape for profit.
The ensuing scandal so outraged Congress that USAID was forced to cancel the prostitute union’s funding — but unfortunately, nothing was done to curb USAID’s grotesque culture of corruption, globalist meddling, and left-wing activism.
Finally, two decades later, President Donald Trump has taken decisive action to cut off USAID’s funding. But with liberal federal judges interceding on behalf of the Washington swamp, the battle is far from over. The only permanent solution is for Congress to shut down this rogue agency for good.
USAID was created in 1961 as part of President John F. Kennedy’s effort to win developing countries to America’s cause in the Cold War against the Soviet menace. Despite such lofty intentions, USAID was quickly captured by left-wing ideologues. The agency has spent decades funneling billions of dollars into dubious projects that advance a radical agenda under the guise of “development” aid.
Recent examples of USAID’s depravity include financing a <a href="https://www.whitehouse.gov/articles/2025/02/at-usaid-waste-and-abuse-runs-deep/" target="_blank" rel="noopener">“transgender opera” in Colombia, producing a “DEI musical” in Ireland</a>, and providing <a href="https://foreignaffairs.house.gov/press-release/chairman-mast-exposes-outrageous-usaid-and-state-department-grants/" target="_blank" rel="noopener">$15 million for condoms to the Taliban</a>. These are not anomalies — they are the logical outcome of an irredeemable agency that has long prioritized social engineering over economic development and national security.
Perhaps the most egregious example remains the sex trafficking scandal in India uncovered in 2005. Despite clear evidence that USAID-funded organizations were facilitating child prostitution, agency officials not only denied involvement but actively obstructed congressional investigators. It was only through relentless congressional oversight that investigators exposed the truth.
And yet, even after the revelations, USAID faced no meaningful consequence — no bureaucrats were prosecuted or fired, no structural reforms were enacted, and the agency continued to operate as usual right up to the present day.
The Trump administration has correctly recognized that USAID is beyond reform. By cutting funding, the White House has struck a major blow against this globalist slush fund. But unless Congress acts, USAID will remain an open wound festering in the federal budget, waiting to be revived by activist judges or the next Democratic administration.
USAID has proven, time and again, that it is unaccountable, wasteful, hostile to American ideals, and antithetical to American interests. It is a weapon of ideological warfare masquerading as a humanitarian agency, using taxpayer money to fund left-wing activism abroad while ignoring real global crises that threaten national security.
The solution is simple: Congress must dismantle and permanently abolish USAID. Foreign aid should be administered through highly targeted programs closely monitored by the State Department, ensuring that assistance truly aligns with strategic interests rather than ideological whims.
President Trump has led the way by shining a light on USAID’s corruption and attempting to turn off the spigot of taxpayer dollars. Now, it’s time for Congress to finish the job and eliminate this agency once and for all.
J. Marc Wheat is the general counsel of Advancing American Freedom.
The views expressed in this piece are those of the author and do not necessarily represent those of The Daily Wire.

Menu

J. Marc Wheat

The FDA’s Review Of Abortion Drugs Is Long Overdue

Why Congress Needs To Permanently Dismantle USAID